Acute promyelocytic leukemia in 57 previously untreated patients

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Cancer

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(19850101)55:1<18::AID-CNCR2820550104>3.0.CO;2-BPMID 3855265
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet consumption and sequestration in severe acute respiratory failure.

  2015cited by this paper
• Classification of acute leukemia.

  2011cited by this paper
• [Bacterial septicemia in neutropenia patients].

  1983cited by this paper
• Infectious complications in leukemic patients.

  1982cited by this paper
• Platelet and neutrophil sequestration after fragment D-induced respiratory distress.

  1982cited by this paper
• Management of adult acute myelogenous leukaemia.

  1981cited by this paper
• Intensive chemotherapy for acute myelogenous leukemia.

  1981cited by this paper
• Progress in acute myeologenous leukemia.

  1981cited by this paper
• Acute tumor lysis syndrome: A review of 37 patients with Burkitt's lymphoma

  1980cited by this paper
• Treatment of acute myelogenous leukemia in children and adults.

  1980cited by this paper
• Acute promyelocytic leukemia—clinical management of 15 patients

  1980cited by this paper
• Efficiency of prophylactic granulocyte transfusions in preventing infections in acute leukaemia.

  1979cited by this paper
• Treatment of acute nonlymphocytic leukemia: use of anthracycline-cytosine arabinoside induction therapy and comparison of two maintenance regimens.

  1979cited by this paper
• Acute Promyelocytic Leukemia: Management of the Coagulopathy During Daunorubicin-Prednisone Remission Induction

  1978cited by this paper
• Disseminated intravascular coagulation in acute promyelocytic leukemia. Possibility of treatment with glucocorticoids at high doses.

  1978cited by this paper
• Prophylactic heparin therapy in acute promyelocytic leukemia

  1978cited by this paper
• Acute promyelocytic leukemia: A review of literature

  1978cited by this paper
• Acute promyelocytic leukemia: results of therapy and analysis of 13 cases.

  1977cited by this paper
• Classification of Acute Leukemia

  1977cited by this paper
• Diagnostic lavage and occult pulmonary hemorrhage in thrombocytopenic immunocompromised patients.

  1977cited by this paper
• [Acute monoblastic leukemia. Clinical and therapeutic aspects in 20 cases].

  1976cited by this paper
• ε-Amino-Caproic Acid in the Management of Acute Promyelocytic Leukaemia

  1976cited by this paper
• Pathologic cells as procoagulant substance of disseminated intravascular coagulation syndrome in acute promyelocytic leukemia.

  1976cited by this paper
• epsilon-Amino-caproic acid in the management of acute promyelocytic leukaemia.

  1976cited by this paper
• Intravascular coagulation associated with the adult respiratory distress syndrome.

  1976cited by this paper
• Occult pulmonary haemorrhage in leukaemia.

  1975cited by this paper
• ACUTE PROMYELOCYTIC LEUKAEMIA: HAEMORRHAGIC MANIFESTATION AND MORPHOLOGIC CRITERIA

  1975cited by this paper
• The Procoagulant Factor of Leukaemic Promyelocytes: Demonstration of Immunologic Cross Reactivity with Human Brain Tissue Factor

  1975cited by this paper
• [Emergency treatment of acute promyelocytic leukemia and its hemorrhagic complications. Apropos of 30 cases].

  1975cited by this paper
• Clinical and morphological correlations in acute promyelocytic leukemia.

  1975cited by this paper
• Treatment of acute leukemia in adults

  1975cited by this paper
• Pathophysiology of the respiratory distress syndrome.

  1974cited by this paper
• Acute Promyelocytic Leukaemia

  1974cited by this paper
• Relationship between Blast‐Cell Morphology and Occurrence of a Syndrome of Disseminated Intravascular Coagulation

  1973cited by this paper
• [The treatment of disseminated intravascular coagulation in 18 cases of promyelocytic acute leukaemia (author's transl)].

  1973cited by this paper
• Studies of the Procoagulant and Fibrinolytic Activity of Promyelocytes in Acute Promyelocytic Leukaemia

  1973cited by this paper
• Management of Adult Acute Myelogenous Leukaemia

  1973cited by this paper
• Combination chemotherapy with cytosine arabinoside and rubidomycin in 30 cases of acute granulocytic leukemia

  1973cited by this paper
• Pulmonary hemorrhage syndrome as a manifestation of disseminated intravascular coagulation: analysis of ten cases.

  1973cited by this paper
• Acute promyelocytic leukemia: results of treatment by daunorubicin.

  1973cited by this paper
• Heparin treatment for the hemorrhagic diathesis of acute promyelocytic leukemia.

  1972cited by this paper
• Intravascular coagulation in acute leukemia: clinical and subclinical abnormalities.

  1972cited by this paper
• Intravascular coagulation in promyelocytic leukemia: a case study including ultrastructure.

  1971cited by this paper
• Disseminated intravascular coagulation, nonbacterial thrombotic endocarditis and adult pulmonary hyaline membranes--an interrelated triad? Report of a case following small bowel resection for a strangulated inguinal hernia.

  1971cited by this paper
• Acute promyelocytic leukemia with disseminated intravascular coagulation.

  1971cited by this paper
• The mechanism of pulmonary damage following traumatic shock.

  1970cited by this paper
• Coagulation defects in acute promyelocytic leukemia.

  1969cited by this paper
• Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults.

  1968cited by this paper
• Pulmonary complications of acute leukemia

  1966cited by this paper
• HYPOFIBRINOGENEMIC HEMORRHAGE IN ACUTE MYELOGENOUS LEUKEMIA TREATED WITH HEPARIN. WITH AUTOPSY FINDINGS OF WIDESPREAD INTRAVASCULAR CLOTTING.

  1964cited by this paper
• ACUTE PROMYELOCYTIC LEUKEMIA WITH FIBRINOGEN AND FACTOR V DEFICIENCIES.

  1964cited by this paper
• [On the pathophysiology of the "respiratory distress-syndrome"].

  1963cited by this paper
• A cytological and histological study of acute premyelocytic leukaemia

  1963cited by this paper
• Acute promyelocytic leukemia associated with hypofibrinogenemia.

  1963cited by this paper
• Acute promyelocytic leukemia.

  1957cited by this paper

• The Coagulopathy of Acute Promyelocytic Leukemia: An Updated Review of Pathophysiology, Risk Stratification, and Clinical Management

  2023cites this paper
• Preoperative haemostatic testing in Sulaimanyia City

  2023cites this paper
• Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia

  2023cites this paper
• Long-term follow-up results of cytarabine-contain-ing chemotherapy for acute promyelocytic leukemia Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemia

  2022cites this paper
• Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemia

  2022cites this paper
• WMA Council Resolution in Support of the Countries Worst Affected by the Covid-19 Crisis

  2021cites this paper
• History of Acute Promyelocytic Leukemia

  2021cites this paper
• Drug treatment options for acute promyelocytic leukemia

  2021cites this paper
• Acute Promyelocytic Leukemia: A Long-Term Retrospective Study in Mexico

  2021cites this paper
• Therapeutic Approaches for Acute Promyelocytic Leukaemia: Moving Towards an Orally Chemotherapy-Free Era

  2020cites this paper
• Thrombotic Thrombocytopenic Purpura, Heparin-Induced Thrombocytopenia, and Disseminated Intravascular Coagulation.

  2020cites this paper
• Acute Promyelocytic Leukemia: A History over 60 Years—From the Most Malignant to the most Curable Form of Acute Leukemia

  2019cites this paper
• Mechanisms and management of coagulopathy in acute promyelocytic leukemia.

  2018cites this paper
• Early Death in APL

  2018cites this paper
• Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives

  2017cites this paper
• Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives

  2017cites this paper
• Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives

  2017cites this paper
• What's new in the pathogenesis of the coagulopathy in acute promyelocytic leukemia?

  2016cites this paper
• A Rare Occurrence of Simultaneous Venous and Arterial Thromboembolic Events – Lower Limb Deep Venous Thrombosis and Pulmonary Thromboembolism as Initial Presentation in Acute Promyelocytic Leukemia

  2016cites this paper
• RAF-1/MEK/ERK pathway regulates ATRA-induced differentiation in acute promyelocytic leukemia cells through C/EBPβ, C/EBPε and PU.1.

  2016cites this paper
• Acute promyelocytic leukemia: where did we start, where are we now, and the future

  2015cites this paper
• Analysis of factors affecting hemorrhagic diathesis and overall survival in patients with acute promyelocytic leukemia

  2015cites this paper
• Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM‐D registry

  2015cites this paper
• Efeitos in vitro e in vivo do Extrato de Glândulas Salivares de Fêmeas de Carrapatos Rhipicephalus sanguineus com 2 Dias de Alimentação Sobre Modelos Tumorais

  2014cites this paper
• Recurrent Arterial and Venous Thromboemboli as Initial Presentation of Acute Promyelocytic Leukemia

  2014cites this paper
• Acute promyelocytic leukemia.

  2014cites this paper
• Prompt all-trans retinoic acid administration and early death in acute promyelocytic leukemia: what does the evidence say?

  2014cites this paper
• Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin

  2014cites this paper
• Treatment of acute promyelocytic leukemia.

  2014cites this paper
• The coagulopathy in acute promyelocytic leukaemia--what have we learned in the past twenty years.

  2014cites this paper
• Delay in the administration of all-trans retinoic acid and its effects on early mortality in acute promyelocytic leukemia: final results of a multicentric study in the United States.

  2014cites this paper
• Etude des micro-ARNs sériques dans les leucémies aiguës myéloïdes : vers une meilleure compréhension épigénétique de la leucémogénèse et une nouvelle approche de l’évaluation pronostique

  2014cites this paper
• Group leukemia. Results of a multicenter randomized trial. European APL 91 Effect of all transretinoic acid in newly diagnosed acute promyelocytic

  2013cites this paper
• Acute Promyelocytic Leukemia in a 17yr Male presenting as Intracerebral Haemorrhage

  2013cites this paper
• Acute Promyelocytic Leukemia-Associated Thrombosis

  2013cites this paper
• Peroxidase activity and nuclear density analysis (PANDA) in the diagnosis of acute promyelocytic leukaemia

  2012cites this paper
• Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia

  2012cites this paper
• Vitamin A and Retinoids: An Update of Biological Aspects and Clinical Applications

  2012cites this paper
• Methionine-induced hyperhomocysteinemia reverts fibrinolytic pathway activation in a murine model of acute promyelocytic leukemia.

  2012cites this paper
• Molecular basis for the diagnosis and treatment of acute promyelocytic leukemia

  2012cites this paper
• The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia

  2012cites this paper
• Treatment advances have not improved the early death rate in acute promyelocytic leukemia

  2012cites this paper
• Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid.

  2011cites this paper
• Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia.

  2011cites this paper
• Should minimal residual disease monitoring be the standard of care for all patients with acute promyelocytic leukemia?

  2011cites this paper
• Acute Promyelocytic Leukemia: A Model Disease for Targeted Cancer Therapy

  2011cites this paper
• Management of Emergencies in Leukemias

  2011cites this paper
• Renal complications in oncologic patients.

  2010cites this paper
• Disseminated Intravascular Coagulation in Hematologic Malignancies

  2010cites this paper
• Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high‐risk myelodysplastic syndrome

  2010cites this paper
• Disseminated intravascular coagulation in hematologic malignancies.

  2010cites this paper
• Renal complications in oncologic patients.

  2009cites this paper
• Coagulation abnormalities in acute promyelocytic leukemia

  2009cites this paper
• The coagulopathy of acute promyelocytic leukaemia revisited.

  2009cites this paper
• HORIZONS I Acute Promyelocytic Leukemia Experience at aNorth Indian Tertiary Care Hospital with Review of Literature •

  2009cites this paper
• [Transfusion in haematology].

  2008cites this paper
• Do paradigma molecular ao impacto no prognóstico: uma visão da leucemia promielocítica aguda

  2008cites this paper
• [From the molecular model to the impact on prognosis: an overview on acute promyelocytic leukemia].

  2008cites this paper
• The double hazard of thrombophilia and bleeding in acute promyelocytic leukemia.

  2007cites this paper
• Treatment of acute promyelocytic leukemia by retinoids.

  2007cites this paper
• Tumors of the brain and spine

  2007cites this paper
• Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy

  2007cites this paper
• Haemostatic problems in acute promyelocytic leukaemia.

  2006cites this paper
• Risk score model for fatal intracranial hemorrhage in acute leukemia

  2006cites this paper
• Ten-year Experience on Acute Promyelocytic Leukemia at Inha University Hospital

  2006cites this paper
• Terson's syndrome in a patient with acute promyelocytic leukemia on all-trans retinoic acid treatment

  2005cites this paper
• Hip pain as the first symptom of acute promyelocytic leukemia: a case report of a pelvic chloroma

  2005cites this paper
• Acute promyelocytic leukemia: A model of molecular target based therapy

  2005cites this paper
• [Acute central nervous symptoms in oncologic patients].

  2005cites this paper
• Akute zentralnervöse Symptome

  2004cites this paper
• Effects of all‐trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia

  2004cites this paper
• Choice of chemotherapy in induction, consolidation and maintenance in acute promyelocytic leukaemia.

  2003cites this paper
• Sarcoma granulocítico de la pelvis en un futbolista: caso clínico

  2002cites this paper
• Acute promyelocytic leukemia: clinical and morphologic features and prognostic factors.

  2001cites this paper
• Treatment of acute promyelocytic leukaemia using a combination of all-trans retinoic acid and chemotherapy.

  2001cites this paper
• Treatment of acute promyelocytic leukaemia.

  2001cites this paper
• Neurologic emergencies in the cancer patient.

  2000cites this paper
• Acute promyelocytic leukemia. From morphology to molecular lesions.

  2000cites this paper
• Treatment of acute promyelocytic leukemia with all- trans retinoic acid

  2000cites this paper
• Commentary on and reprint of Huang M-E, Ye Y-C, Chen S-R, Chai J-R, Lu J-X, Zhoa L, Gu L-J, Wang Z-Y, Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia, in Blood (1988) 72:567–572

  2000cites this paper
• CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome?

  1999cites this paper
• Knochenmark und myelogene Neoplasien

  1999cites this paper
• Acute progranulocytic leukaemia: A model for molecular medicine

  1999cites this paper
• Acute promyelocytic leukemia: All‐trans retinoic acid (ATRA) along with chemotherapy is superior to ATRA alone

  1999cites this paper
• The Thrombophilic State in Acute Promyelocytic Leukemia

  1999cites this paper
• Short-term intensive consolidation therapy after all-trans retinoic acid in acute promyelocytic leukemia.

  1999cites this paper
• Effect of all-trans retinoic acid on newly diagnosed acute promyelocytic leukemia patients: results of a Brazilian center.

  1998cites this paper
• Renal complications in acute leukemias.

  1998cites this paper
• All-trans-retinoic acid (ATRA): pediatric acute promyelocytic leukemia.

  1998cites this paper
• Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosis

  1998cites this paper
• Effect of all-trans-retinoic acid alone or in combination with chemotherapy in newly diagnosed acute promyelocytic leukaemia

  1997cites this paper
• Improvement of prognosis in refractory and relapsed acute promyelocytic leukemia over recent years: the role of all-trans retinoic acid therapy

  1997cites this paper
• Coagulation patterns of disseminated intravascular coagulation in acute promyelocytic leukemia

  1997cites this paper
• Acute promyelocytic leukemia: biology and treatment.

  1997cites this paper
• All-trans-retinoic acid in acute promyelocytic leukemia.

  1997influential citation
• Deciphering the pathogenesis of coagulation dysfunction in leukemia.

  1996cites this paper
• Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.

  1996cites this paper
• Treatment of acute promyelocytic leukaemia.

  1996cites this paper
• Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg/dl.

  1996cites this paper
• ALL‐TRANS RETINOIC ACID (ATRA) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL)

  1996cites this paper